These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15112967)

  • 41. Multiparameter comparison of injection laryngoplasty, medialization laryngoplasty, and arytenoid adduction in an excised larynx model.
    Hoffman MR; Witt RE; Chapin WJ; McCulloch TM; Jiang JJ
    Laryngoscope; 2010 Apr; 120(4):769-76. PubMed ID: 20213797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Revision laryngeal surgery for the suboptimal injection of calcium hydroxylapatite.
    Chheda NN; Rosen CA; Belafsky PC; Simpson CB; Postma GN
    Laryngoscope; 2008 Dec; 118(12):2260-3. PubMed ID: 19029857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of gender and injection site on vocal fold augmentation.
    Mau T; Courey MS
    Otolaryngol Head Neck Surg; 2008 Feb; 138(2):221-5. PubMed ID: 18241720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A meta-analysis of voice outcome comparing calcium hydroxylapatite injection laryngoplasty to silicone thyroplasty.
    Shen T; Damrose EJ; Morzaria S
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):197-208. PubMed ID: 23077153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiparameter analysis of titanium vocal fold medializing implant in an excised larynx model.
    Witt RE; Hoffman MR; Friedrich G; Rieves AL; Schoepke BJ; Jiang JJ
    Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):125-32. PubMed ID: 20336924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medialization laryngoplasty for the treatment of unilateral vocal cord paralysis: a perceptual, acoustic and stroboscopic evaluation.
    Hamdan AL; Mokarbel R; Dagher W
    J Med Liban; 2004; 52(3):136-41. PubMed ID: 16432970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The biomechanics of the medialization laryngoplasty (thyroplasty type 1) in an ex vivo canine model.
    Noordzij JP; Opperman DA; Perrault DF; Woo P
    J Voice; 1998 Sep; 12(3):372-82. PubMed ID: 9763188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term treatment results for unilateral vocal fold palsy induced by mediastinal lesions.
    Lee YS; Kim YH; Kwon M; Ryu IS; Jung GE; Kim ST; Roh JL; Choi SH; Kim SY; Nam SY
    J Voice; 2014 Nov; 28(6):809-15. PubMed ID: 25008380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Voice outcomes of polyacrylamide hydrogel injection laryngoplasty.
    Lee SW; Son YI; Kim CH; Lee JY; Kim SC; Koh YW
    Laryngoscope; 2007 Oct; 117(10):1871-5. PubMed ID: 17690620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous injection laryngoplasty in the management of acute vocal fold paralysis.
    Damrose EJ
    Laryngoscope; 2010 Aug; 120(8):1582-90. PubMed ID: 20641072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managing voice impairment after injection laryngoplasty.
    Ting JY; Patel R; Halum SL
    J Voice; 2012 Nov; 26(6):797-800. PubMed ID: 22633331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy of unilateral vocal fold paralysis with polydimethylsiloxane injection laryngoplasty: our experience.
    Bergamini G; Alicandri-Ciufelli M; Molteni G; Villari D; Luppi MP; Genovese E; Presutti L
    J Voice; 2010 Jan; 24(1):119-25. PubMed ID: 19185462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modified thyroplasty for unilateral vocal fold paralysis using an adjustable titanium implant.
    Wen W; Sun G; Sun B; Liu C; Zhang M
    Eur Arch Otorhinolaryngol; 2015 Mar; 272(3):517-22. PubMed ID: 24728279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short- and long-term outcomes after silastic medicalization laryngoplasty: are arytenoid procedures needed?
    Benninger MS; Manzoor N; Ruda JM
    J Voice; 2015 Mar; 29(2):236-40. PubMed ID: 25510165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term result of the new endoscopic vocal fold medialization surgical technique for laryngeal palsy.
    Nishiyama K; Hirose H; Masaki T; Nagai H; Hashimoto D; Usui D; Yao K; Tsunoda K; Okamoto M
    Laryngoscope; 2006 Feb; 116(2):231-4. PubMed ID: 16467710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histopathologic study of alternative substances for vocal fold medialization.
    Stein J; Eliachar I; Myles J; Munoz-Ramirez H; Strome M
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):221-6. PubMed ID: 10685577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hydroxyapatite versus titanium implant: Comparison of the functional outcome after vocal fold medialization in unilateral recurrent nerve paralysis.
    Storck C; Fischer C; Cecon M; Schmid S; Gambazzi F; Wolfensberger M; Brockmann M
    Head Neck; 2010 Dec; 32(12):1605-12. PubMed ID: 20310039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of office-based percutaneous injection laryngoplasty with calcium hydroxylapatite.
    Lee M; Lee DY; Kwon TK
    Laryngoscope; 2019 Oct; 129(10):2361-2365. PubMed ID: 30756397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of arytenoid adduction on laryngeal function following ansa cervicalis nerve transfer for vocal fold paralysis in an in vivo canine model.
    Nasri S; Sercarz JA; Ye M; Kreiman J; Gerratt BR; Berke GS
    Laryngoscope; 1994 Oct; 104(10):1187-93. PubMed ID: 7934586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Injection laryngoplasty outcomes in vocal fold paralysis using calcium hydroxylapatite.
    Koçdor P; Tulunay-Uğur ÖE
    Kulak Burun Bogaz Ihtis Derg; 2014; 24(5):271-5. PubMed ID: 25513870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.